From January 1, 2024 to January 24, 2024, the company has repurchased 218,902 shares, representing 0.32% for KRW 7,411.72 million. With this, the company has completed the repurchase of 268,859 shares, representing 0.4% for KRW 9,341.62 million under the buyback announced on October 24, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
33,250 KRW | -0.60% |
|
+0.30% | -15.18% |
Jul. 10 | Hanmi Pharm Chair to Resign from Management | MT |
May. 16 | Hanmi Science Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-15.18% | 1.63B | |
+25.65% | 45.54B | |
+34.52% | 24.51B | |
+26.46% | 16.48B | |
+21.20% | 14.66B | |
+71.37% | 14.3B | |
-0.05% | 6.79B | |
-11.84% | 6.73B | |
+18.15% | 5.87B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- A008930 Stock
- News Hanmi Science Co., Ltd.
- Tranche Update on Hanmi Science Co., Ltd.'s Equity Buyback Plan announced on October 24, 2023.